On this page
RFXAP
regulatory factor X associated protein
The RFXAP gene provides instructions for making a protein that is essential for the proper functioning of the immune system, primarily by regulating the activity of major histocompatibility complex class II genes. RFXAP plays a vital role in immune response by ensuring the production of MHC class II proteins, which are critical for immune cells to recognise and combat foreign invaders.
RFXAP is located on the long (q) arm of chromosome 13, at band 13q13.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 13 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The RFXAP gene, or regulatory factor X associated protein, is fundamental to the body's immune system. It encodes a protein, also called RFXAP, which is part of a larger protein complex known as the regulatory factor X (RFX) complex. This complex is crucial for controlling the activity of major histocompatibility complex (MHC) class II genes.
MHC class II proteins are specialised immune proteins found on the surface of certain immune cells. They are essential for presenting fragments of foreign invaders, such as bacteria or viruses, to other immune cells, thereby initiating an appropriate immune response. Disruptions in the RFXAP gene can impair this critical process, leading to severe immune deficiencies.
What the gene does
The RFXAP protein is a key component of the regulatory factor X (RFX) complex. This complex binds to specific DNA regions, regulating the transcription of major histocompatibility complex (MHC) class II genes. RFXAP's role within this complex is to help anchor the complex to the correct DNA sequence, facilitating the recruitment of other proteins necessary for gene activation. This process ensures the production of MHC class II proteins.
MHC class II proteins are present on the surface of immune cells, including lymphocytes, where they bind to peptides from foreign pathogens. This binding allows other specialised immune cells to recognise the peptides as harmful, triggering a targeted immune response to eliminate the invaders. While primarily regulating MHC class II genes, the RFX complex, including RFXAP, also contributes to the transcription of MHC class I genes, which serve a similar function in presenting antigens to immune cells, though other proteins are the primary regulators for MHC class I activity.
Video: Genetics 101
Chromosome location
The RFXAP gene is situated on chromosome 13, specifically at position 13q13.3. This location specifies the precise band on the long (q) arm of chromosome 13 where the gene can be found. The RFXAP gene provides the genetic blueprint for a protein consisting of 272 amino acid residues.
Protein structure
The RFXAP protein is composed of 272 amino acids and contains several distinct regions that contribute to its function. The protein includes multiple disordered regions, located at amino acids 1-20, 74-142, and 175-195. These intrinsically disordered regions often play roles in protein-protein interactions and signalling. A nuclear localisation signal (Motif) is identified between amino acids 163-178, which is crucial for directing the RFXAP protein into the cell nucleus where it performs its regulatory functions. Additionally, a C-terminal domain (Region) is present from amino acids 214-270, which may also be important for protein interactions or stability.
Key variants
Variants within the RFXAP gene can lead to changes in the RFXAP protein, potentially affecting its ability to regulate MHC class II gene expression and thus impairing immune function. These genetic alterations can include small changes in DNA sequence, such as point mutations, or larger deletions or insertions. The impact of a specific variant depends on its location and the resulting alteration to the protein structure or function.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.259del | p.Glu87fs | Pathogenic/Likely pathogenic | ★★☆☆ | MHC class II deficiency |
c.368del | p.Ser123fs | Pathogenic | ★★☆☆ | MHC class II deficiency 1 |
c.188del | p.Gly63fs | Pathogenic | ★☆☆☆ | MHC class II deficiency |
c.203dup | p.Lys69fs | Pathogenic | ★☆☆☆ | MHC class II deficiency |
c.244G>T | p.Glu82Ter | Pathogenic | ★☆☆☆ | MHC class II deficiency |
c.279dup | p.Asp94fs | Pathogenic | ★☆☆☆ | MHC class II deficiency |
c.320dup | p.Ser107fs | Pathogenic | ★☆☆☆ | MHC class II deficiency 4 |
c.359del | p.Gly120fs | Pathogenic | ★☆☆☆ | MHC class II deficiency |
c.359dup | p.Glu121fs | Pathogenic | ★☆☆☆ | MHC class II deficiency |
c.634C>T | p.Gln212Ter | Pathogenic | ★☆☆☆ | not provided |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the RFXAP gene are primarily associated with inherited immune system disorders. Notably, these include Bare Lymphocyte Syndrome Type II (BLS II), a form of combined immunodeficiency where individuals have severely compromised immune protection against foreign invaders. Individuals with BLS II often experience recurrent and persistent infections affecting various bodily systems, including the respiratory, gastrointestinal, and urinary tracts.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
The RFXAP gene is featured on NHS England's National Genomic Test Directory for specific clinical applications. It is listed as 'green' on the COVID-19 research panel, indicating its relevance to studies concerning the virus. Additionally, RFXAP is green on the R15 panel for Primary immunodeficiency or monogenic inflammatory bowel disease, highlighting its importance in diagnosing and understanding these conditions within the UK healthcare system.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary role of the RFXAP gene?
The RFXAP gene provides instructions for making a protein that is a part of the RFX complex. This complex helps regulate the activity of MHC class II genes, which are crucial for the immune system's ability to recognise and fight off infections.
What is Bare Lymphocyte Syndrome Type II?
Bare Lymphocyte Syndrome Type II (BLS II) is an inherited immunodeficiency caused by variants in genes like RFXAP. It results in a severely compromised immune system, making affected individuals highly susceptible to recurrent infections.
How does RFXAP relate to MHC class II proteins?
The RFXAP protein helps the RFX complex bind to specific DNA regions, initiating the production of MHC class II proteins. These proteins are essential for presenting pathogen fragments to other immune cells, which then launch an immune response.
References
- Gokturk B, Artac H, van Eggermond MJ. Type III bare lymphocyte syndrome associated with a novel RFXAP mutation: a case report. International journal of immunogenetics. 2012. PMID: 22390233
- Briggs L, Laird K, Boss JM. Formation of the RFX gene regulatory complex induces folding of the interaction domain of RFXAP. Proteins. 2009. PMID: 19274739
- Garvie CW, Boss JM. Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5. Biochimica et biophysica acta. 2008. PMID: 18723135
- Burd AL, Ingraham RH, Goldrick SE. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins. Biochemistry. 2004. PMID: 15461447
- Gobin SJ, Peijnenburg A, van Eggermond M. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. Immunity. 1998. PMID: 9806639
- Villard J, Lisowska-Grospierre B, van den Elsen P. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. The New England journal of medicine. 1997. PMID: 9287230